8-K: UpHealth Amends Debt Agreements, Secures Support for Cloudbreak Sale

UpHealth, Inc. has amended its debt agreements and secured support from noteholders for the sale of its Cloudbreak subsidiary.

Summary

• UpHealth, Inc. has entered into a supplemental indenture and amendment to its security and pledge agreement, modifying the terms of its 2025 Notes.
• The company also entered into a supplemental indenture to its 2026 Notes, adding subsidiary guarantees and a second-priority security interest.
• These amendments were made with the consent of holders representing over 75% of the principal amount of each series of notes.
• The amendments include changes to definitions, covenants, and events of default, as well as a carveout for the Cloudbreak sale.
• The company also entered into an intercreditor agreement with the trustees and collateral agents of the 2025 and 2026 Notes.
• The company has also secured waivers from noteholders for certain defaults related to its bankruptcy proceedings.
• The company has agreed to a multi-step process for the repurchase of the 2025 Notes at a 5% premium to the principal amount.
• The company has agreed to offer to repurchase the 2026 Notes at 100% of the principal amount plus accrued interest, subject to certain conditions.
• The company has also agreed to certain limitations on its ability to incur additional debt and grant liens.
• The company has agreed to certain limitations on its ability to make restricted payments and asset sales.

Sentiment

Score: 6

Explanation: The document is primarily factual and legal in nature, detailing amendments to debt agreements and waivers. While it secures support for a sale, it also highlights ongoing financial challenges and restrictions. The sentiment is neutral to slightly positive.

Positives

• The company has secured support from noteholders for the Cloudbreak sale.
• The company has amended its debt agreements to facilitate the sale.
• The company has obtained waivers for certain defaults related to its bankruptcy proceedings.

Negatives

• The company is still subject to certain restrictions on its ability to incur additional debt and grant liens.
• The company is still subject to certain restrictions on its ability to make restricted payments and asset sales.

Risks

• The company is still subject to certain restrictions on its ability to incur additional debt and grant liens.
• The company is still subject to certain restrictions on its ability to make restricted payments and asset sales.
• The company is still subject to certain risks related to its bankruptcy proceedings.
• The company is still subject to certain risks related to the Cloudbreak sale.

Future Outlook

The company expects the Cloudbreak sale to close on the third business day following stockholder approval and satisfaction of other closing conditions, but no earlier than March 15, 2024.

Industry Context

This announcement is related to the company's efforts to restructure its debt and streamline its operations through the sale of a subsidiary. This is a common strategy for companies facing financial challenges.

Comparison to Industry Standards

• The use of supplemental indentures and intercreditor agreements is a standard practice in debt restructuring.
• The repurchase offers at a premium are common in situations where a fundamental change has occurred.
• The waivers and rescission agreements are common in situations where a company is facing bankruptcy proceedings.

Legal Proceedings

• The company is involved in chapter 11 proceedings pending before the United States Bankruptcy Court for the District of Delaware under caption In re UpHealth Holdings, Inc., Case No. 23-11476-LSS.

Stakeholder Impact

• Shareholders will vote on the proposed sale of Cloudbreak.
• Noteholders will have the opportunity to have their notes repurchased.
• Employees may be affected by the sale of Cloudbreak.

Next Steps

• The company will hold a special meeting of stockholders on February 29, 2024 to approve the Cloudbreak sale.
• The company will complete the Cloudbreak sale on the third business day following stockholder approval and satisfaction of other closing conditions, but no earlier than March 15, 2024.
• The company will make a repurchase offer for the 2025 Notes at a 5% premium.
• The company will make a repurchase offer for the 2026 Notes at 100% of the principal amount plus accrued interest, subject to certain conditions.

Key Dates

Keywords

Cloudbreak, UpHealth, debt, notes, indenture, security agreement, sale, repurchase, amendment, waiver, collateral, guarantee